Literature DB >> 19688127

Clinical factors related to suspected second primary lung cancer development in patients with head and neck cancer.

Eui Bae Kim1, Yong Park, Seh Jong Park, Dae Sik Kim, Jee Won Kim, Hee Yun Seo, Hwa Jung Sung, In Keun Choi, Kyong Hwa Park, Sang Cheul Oh, Chul Won Choi, Byung Soo Kim, Yeul Hong Kim, Jun Suk Kim, Sang Won Shin, Chul Yong Kim, Kwang-Yoon Jung.   

Abstract

PURPOSE: The rate of second primary lung cancer development for patients with head and neck cancer (HNC) has been noted. The aim of our study was to evaluate the incidence and clinical features of suspected second primary lung cancer that developed in patients with primary HNC.
MATERIALS AND METHODS: We conducted a retrospective study of 469 patients who were newly diagnosed with HNC at the Korea University Medical Center between January 2000 and December 2006.
RESULTS: A total of 469 patients were included (389 men and 80 women). Eighteen patients (3.8%) had suspected second primary lung cancers. Statistically significant clinical variables for lung cancer development included the origin site for the primary HNC (oro-hypopharynx and larynx) (p=0.048), abnormal chest x-ray findings (p=0.027) and the histological HNC type (squamous cell carcinoma) (p=0.032). When the second primary lung cancers were combined with HNCs, the adjusted overall survival of patients with a second primary lung cancer was 16 months (p<0.001).
CONCLUSIONS: Considering the relative risk factors for a second primary lung cancer developing in patients with HNC, advanced diagnostic tools, such as chest CT or PET CT scan, should be applied for the early detection of a second primary lung cancer.

Entities:  

Keywords:  Chest x-ray; Head and neck neoplasms; Second primary cancer

Year:  2008        PMID: 19688127      PMCID: PMC2697475          DOI: 10.4143/crt.2008.40.4.178

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  21 in total

1.  Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin.

Authors:  D P SLAUGHTER; H W SOUTHWICK; W SMEJKAL
Journal:  Cancer       Date:  1953-09       Impact factor: 6.860

Review 2.  Current clinical outcomes demand new treatment options for SCCHN.

Authors:  J-L Lefebvre
Journal:  Ann Oncol       Date:  2005       Impact factor: 32.976

3.  World Health Organization classification of tumours: pathology and genetics of head and neck tumours.

Authors:  Lester Thompson
Journal:  Ear Nose Throat J       Date:  2006-02       Impact factor: 1.697

4.  Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck.

Authors:  A T Choy; C A van Hasselt; E M Chisholm; S R Williams; W W King; A K Li
Journal:  Cancer       Date:  1992-08-15       Impact factor: 6.860

5.  A rational approach to pulmonary screening in newly diagnosed head and neck cancer.

Authors:  Kwok Seng Loh; Dale H Brown; James T Baker; Ralph W Gilbert; Patrick J Gullane; Jonathan C Irish
Journal:  Head Neck       Date:  2005-11       Impact factor: 3.147

6.  Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives.

Authors:  I J Dhooge; M De Vos; P B Van Cauwenberge
Journal:  Laryngoscope       Date:  1998-02       Impact factor: 3.325

7.  Temporal relationship between cancers of the lung and upper aerodigestive tract.

Authors:  W C Hsieh; Y M Chen; R P Perng
Journal:  Jpn J Clin Oncol       Date:  1997-04       Impact factor: 3.019

8.  Secondary primary malignancies in head and neck squamous cell carcinoma.

Authors:  M A Rafferty; T P O'Dwyer
Journal:  J Laryngol Otol       Date:  2001-12       Impact factor: 1.469

9.  Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries.

Authors:  Ghislaine Scélo; Paolo Boffetta; Marilys Corbex; Kee-Seng Chia; Kari Hemminki; Soren Friis; Eero Pukkala; Elisabete Weiderpass; Mary L McBride; Elizabeth Tracey; David H Brewster; Vera Pompe-Kirn; Erich V Kliewer; Jon M Tonita; Carmen Martos; Jon G Jonasson; Paul Brennan
Journal:  Cancer Causes Control       Date:  2007-01-19       Impact factor: 2.506

10.  Second primary tumors in patients with head and neck squamous cell carcinoma.

Authors:  A S Jones; P Morar; D E Phillips; J K Field; D Husband; T R Helliwell
Journal:  Cancer       Date:  1995-03-15       Impact factor: 6.860

View more
  3 in total

1.  African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.

Authors:  Yusra F Shao; Seongho Kim; John D Cramer; Dina Farhat; Jeffrey Hotaling; Syed Naweed Raza; George Yoo; Ho-Sheng Lin; Harold Kim; Ammar Sukari; Misako Nagasaka
Journal:  Head Neck       Date:  2022-06-17       Impact factor: 3.821

2.  Second Primary Lung Cancer with Glottic Laryngeal Cancer as Index Tumor - A Case Report.

Authors:  Jamal Akhtar; Rakesh Bhargava; Mohammad Shameem; Saurabh K Singh; Ummul Baneen; Nafees Ahmad Khan; Jassem Hassan; Prakhar Sharma
Journal:  Case Rep Oncol       Date:  2010-02-02

3.  Should fluorodeoxyglucose positron emission tomography/computed tomography be the first-line imaging investigation for restaging the laryngeal carcinoma patients?

Authors:  Tarun Kumar Jain; Guman Singh; Sumit Goyal; Ajay Yadav; Dinesh Yadav; Nitin Khunteta; Hemant Malhotra
Journal:  World J Nucl Med       Date:  2021-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.